Malaria drug-sensitivity testing: New assays, new perspectives

Trends in Parasitology

Volumn 19, Issue 4, 2003, Pages 175-181

  Noedl, Harald ^a   Wongsrichanalai, Chansuda ^b   Wernsdorfer, Walther H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; HISTIDINE; LACTATE DEHYDROGENASE; PROTEIN;

ANTIBIOTIC RESISTANCE; DRUG SENSITIVITY; IN VITRO STUDY; MALARIA; MOLECULAR BIOLOGY; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; REVIEW; SCHIZONT;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTOZOA;

EID: 0344838487     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(03)00028-X     Document Type: Review

References (58)

1. Trape J.F., et al. Combating malaria in Africa. Trends Parasitol. 18:2002;224-230.
2. Bloland, P. (2001) Drug Resistance in Malaria. WHO/CDS/DRS.4. Geneva, WHO.
3. World Health Organization (1973) Chemotherapy of Malaria and Resistance to Antimalarials. Report of a WHO scientific group. WHO Technical Report Series, No. 529. Geneva, WHO.
4. Sibley C.H., et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17:2001;582-588.
5. Winstanley P.A. Chemotherapy for falciparum malaria: the armoury, the problems and the prospects. Parasitol. Today. 16:2000;146-153.
6. White N.J. The assessment of antimalarial drug efficacy. Trends Parasitol. 18:2002;458-464.
7. World Health Organization (1996) Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas With Intense Transmission. WHO/MAL/96.1077. Geneva, WHO.
8. Snounou G., Beck H.P. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol. Today. 14:1998;462-467.
9. Wernsdorfer W.H., Payne D. Drug sensitivity tests in malaria parasites. Wernsdorfer W.H., McGregor I. Malaria. Principles and Practice of Malariology. 1988;1765-1800 Churchill Livingstone.
10. Makler M.T., et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Trop. Med. Hyg. 48:1993;739-741.
11. Druilhe P., et al. A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on highly sensitive double-site pLDH antigen capture ELISA. Am. J. Trop. Med. Hyg. 64:2001;233-241.
12. Noedl H., et al. Histidine rich protein II, a novel approach to antimalarial drug susceptibility testing. Antimicrob. Agents Chemother. 46:2002;1658-1664.
13. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
14. Haynes J.D., et al. Culture of human malaria parasites Plasmodium falciparum. Nature. 263:1976;767-769.
15. Diggs C., et al. Protein synthesis in vitro by cryopreserved Plasmodium falciparum. Am. J. Trop. Med. Hyg. 24:1975;760-763.
16. Duraisingh M.T., et al. Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study. Parasitology. 119:1999;435-440.
17. Zhang Y., et al. Stage-dependent inhibition of chloroquine on Plasmodium falciparum in vitro. J. Parasitol. 72:1986;830-836.
18. Rieckmann K.H., et al. Effects of chloroquine, quinine, and cycloguanil upon the maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 17:1968;661-671.
19. Rieckmann, K.H. et al. (1978) Drug sensitivity of Plasmodium falciparum. An in vitro micro technique. Lancet i, 22-23.
20. World Health Organization (1990) In vitro Micro-Test (Mark II) for the Assessment of the Response of Plasmodium falciparum to Chloroquine, Mefloquine, Quinine, Sulfadoxine/Pyrimethamine and Amodiaquine. WHO/MAP/87.2, Rev.1. Geneva, WHO.
21. Richards W.H., Maples B.K. Studies on Plasmodium falciparum in continuous cultivation. I. The effect of chloroquine and pyrimethamine on parasite growth and viability. Ann. Trop. Med. Parasitol. 73:1979;99-108.
22. Nguyen-Dinh P., Trager W. Plasmodium falciparum in vitro: determination of chloroquine sensitivity of three new strains by a modified 48-hour test. Am. J. Trop. Med. Hyg. 29:1980;339-342.
23. Nguyen-Dinh P., Payne D. Pyrimethamine sensitivity in Plasmodium falciparum: determination in vitro by a modified 48-hour test. Bull. WHO. 58:1980;909-912.
24. van Vianen P.H., et al. Automated flow cytometric analysis of drug susceptibility of malaria parasites. Am. J. Trop. Med. Hyg. 43:1990;602-607.
25. Saito-Ito A., et al. A rapid, simple and sensitive flow cytometric system for detection of Plasmodium falciparum. Parasitol Int. 50:2001;249-257.
26. Smeijsters L.J., et al. Simple, fast, and accurate fluorometric method to determine drug susceptibility of Plasmodium falciparum in 24-well suspension cultures. Antimicrob. Agents Chemother. 40:1996;835-838.
27. Desjardins R.E., et al. Quantitative assessment of anti-malarial activity in vitro by a semi-automated microdilution technique. Antimicrob. Agents Chemother. 16:1979;710-718.
28. Elabbadi N., et al. Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique. Antimicrob. Agents Chemother. 36:1992;50-55.
29. Makler M.T., Hinrichs D.J. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am. J. Trop. Med. Hyg. 48:1993;205-210.
30. Sherman I.W. Heterogeneity of lactic dehydrogenase in avian malaria (Plasmodium lophurae). J. Exp. Med. 114:1961;1049-1062.
31. Piper R., et al. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am. J. Trop. Med. Hyg. 60:1999;109-118.
32. Oduola A.M., et al. Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria. Exp. Parasitol. 87:1997;283-289.
33. Sherman I.W. Carbohydrate metabolism in asexual stages. Sherman I.W. Malaria. Parasite Biology, Pathogenesis, and Protection. 1998;135-144 ASM Press.
34. Basco L.K., et al. Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay. Exp. Parasitol. 80:1995;260-271.
35. Piper R., et al. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am. J. Trop. Med. Hyg. 60:1999;109-118.
36. Moreno A., et al. Evaluation under field conditions of the colourimetric DELI-microtest for the assessment of Plasmodium falciparum drug resistance. Trans. R. Soc. Trop. Med. Hyg. 95:2001;100-103.
37. Moreno A., et al. Use of the DELI-microtest to determine the drug sensitivity of Plasmodium falciparum in Burkina Faso. Ann. Trop. Med. Parasitol. 95:2001;309-312.
38. Wongsrichanalai C. Rapid diagnostic techniques for malaria control. Trends Parasitol. 17:2001;307-309.
39. Desakorn V., et al. Semi-quantitative measurement of Plasmodium falciparum antigen PfHRP2 in blood and plasma. Trans. R. Soc. Trop. Med. Hyg. 91:1997;479-483.
40. Howard R.J., et al. Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J. Cell Biol. 103:1986;1269-1277.
41. Mayxay H., et al. Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 95:2001;179-182.
42. Fryauff D.J., et al. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am. J. Trop. Med. Hyg. 59:1998;513-518.
43. Rieckmann, K.H. et al. (1989) Plasmodium vivax resistance to chloroquine? Lancet ii, 1183-1184.
44. Baird J.K., et al. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans. R. Soc. Trop. Med. Hyg. 90:1996;409-411.
45. Bass C.C., Johns F.M. The cultivation of material plasmodia (Plasmodium vivax and Plasmodium falciparum) in vitro. J. Exp. Med. 16:1912;567-579.
46. Chotivanich K., et al. Ex-vivo short-term culture and developmental assessment of Plasmodium vivax. Trans. R. Soc. Trop. Med. Hyg. 95:2001;677-680.
47. Brockelman C.R., et al. Development of in vitro microtest for the assessment of Plasmodium vivax sensitivity to chloroquine. Southeast Asian J. Trop. Med. Public Health. 20:1989;41-47.
48. Russel, B.M. et al. Simple in vitro assay for determining the sensitivity of P. vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob. Agents Chemother. (in press).
49. Tasanor O., et al. An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine. Acta Trop. 83:2002;49-61.
50. Congpuong K., et al. Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand. Acta Trop. 83:2002;117-121.
51. Lee M.A. Real-time fluorescence-based PCR for detection of malaria parasites. J. Clin. Microbiol. 40:2002;4343-4345.
52. Hermsen C.C. Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol. Biochem. Parasitol. 118:2001;247-251.
53. Nzila A.M., et al. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob. Agents Chemother. 44:2000;991-996.
54. Wongsrichanalai C., et al. Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2:2002;209-218.
55. Kublin J.G., et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185:2002;380-388.
56. Djimde A., et al. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:2001;257-263.
57. Djimde A., et al. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet. 358:2001;890-891.
58. Wellems T.E., Plowe C.V. Chloroquine-resistant malaria. J. Infect. Dis. 184:2001;770-776.